China's pharmaceutical group, Shiyao Group (01093.HK): SYH2085 tablets have been approved for clinical trials in China.

Tencent Finance APP News, Stone Pharmaceutical Group (01093.HK) announced that the SYH2085 tablets developed by the group have been approved by the National Medical Products Administration of the People's Republic of China and can conduct clinical trials in China.